1

The Blue Pill and Big Pharma: A Risky Investment?

News Discuss 
The history of Sildenafil offers a complicated case study for investors eyeing pharma. While initial sales were explosive, current patent expiry and the rise of generic versions have significantly impacted earnings. https://deborahakpu859669.losblogos.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story